Scientific Information

Organising Institutions

Birth and Culture – Nascita e Cultura

Nascita e Cultura is a non-profit association inspired by the values of scientific, deontological and bioethical culture in life sciences which aims to affirm, promote and enhance the global culture of the health of the mother, the fetus and the newborn, understood as the achievement of the highest degree of mental, physical and social well-being, according to the guidelines of the World Health Organization.

Congress Committees

Presidents
Virology
 
Immunology
Pediatrics
 
Epidemiology
Fetal Medicine
 

Scientific Programme

10:00-11:00

REGISTRATION

11:00-11:10

WELCOME

Yves VILLE (F)

11:10-11:30

Priorities for current research: Results of a European survey

Pamela VALLELY (UK)

11:30-11:50

Patients’ voice. Their priorities:

Anne Hélène LABISSY (F)

11:50-12:00

Discussion

12:00-13:30

EPIDEMIOLOGY IN EUROPE

Chairs: Susanne Smit, Belgium; Marianne Leruez, France

12:00-12:20

Overview

Susanne Smit, Belgium

12:20-12:40

The high risk group

Marianne LERUEZ (F)

12:40-12:50

FREE COMMUNICATION 1

12:50-13:00

FREE COMMUNICATION 2

13:00-13:10

FREE COMMUNICATION 3

13:10-13:20

FREE COMMUNICATION 4

13:20-13:30

Discussion

13:30-15:00

LUNCH BREAK AND POSTER VIEW

15:00-17:00

PREVENTION

Chairs: Chrissie Jones, United Kingdom; Arnauld Marchant, Belgium

15:00-15:50

PRIMARY PREVENTION

15:00-15:20

Overview

Chrissie JONES (UK)

15:20-15:30

FREE COMMUNICATION 1

15:30-15:40

FREE COMMUNICATION 2

15:40-15:50

Discussion

15:50-17:00

SECONDARY PREVENTION

15:50-16:30

Debate:

Klaus Hamprecht
HIIG do not work: Brenna Anderson (USA)
HIIG work: « How to otimize passive immunization for prevention of maternofetal CMV transmission: impact of virological inclusion criteria »

16:30-16:50

Val-acyclovir to Prevent congenital CMV After Maternal Primary Infection early in Pregnancy

Jacob Amir, Israel

16:50-17:00

FREE COMMUNICATION 1

09:00-10:10

DIAGNOSTIC OF MATERNAL INFECTION

Chairs: Ann VOSSEN (NL), Tiziana LAZZAROTTO (I)

09:00-09:20

Overview primary infection

Tiziana LAZZAROTTO (I)

09:20-09:40

Overview Non-primary infection

Daniele LILLERI (I)

09:40-09:50

FREE COMMUNICATION 1

09:50-10:00

FREE COMMUNICATION 2

10:00-10:10

FREE COMMUNICATION 3

10:10-11:00

DIAGNOSTIC OF FETAL INFECTION

Chairs: Catherine DONNER (B), Anna GONCE (S)

10:10-10:30

Overview

Yves VILLE (F)

10:30-10:40

FREE COMMUNICATION 1

10:40-10:50

FREE COMMUNICATION 2

10:50-17:00

Discussion

11:00-11:30

COFFEE BREAK AND POSTER VIEW

11:30-11:40

FREE COMMUNICATION 2

11:40-11:50

FREE COMMUNICATION 3

11:50-12:00

Discussion

12:00-13:30

TERTIARY PREVENTION (Fetal and Neonatal treatment)

12:00-12:20

Antiviral treatment in pregnancy

Marianne LERUEZ (F)

12:20-12:40

Neonatal treatment (overview)

Ann VOSSEN (NL)

12:40-12:50

FREE COMMUNICATION 1

12:50-13:00

FREE COMMUNICATION 2

13:00-13:10

FREE COMMUNICATION 3

13:10-13:20

FREE COMMUNICATION 4

13:20-13:30

Discussion

13:30-15:00

LUNCH BREAK AND POSTER VIEW

15:00-15:20

VACCINE quo vadis

15:00-15:20

Overview

Arnauld MARCHANT (B)

15:20-16:30

PEDIATRICS - PART 1

Chairs: Daniel BLASQUEZ (S), Ina FOULON (B)

15:20-15:40

Management of NSHL

Ina FOULON (B)

15:40-16:00

Implants: technique and outcome

Natacha TESSIER (F)

16:00-16:10

FREE COMMUNICATION 1

16:10-16:20

FREE COMMUNICATION 2

16:20-16:30

Discussion

09:00-11:00

PEDIATRICS - PART II

Chairs: Daniel BLASQUEZ (S), Ina FOULON (B)

09:00-09:20

Pediatric burden of non-primary infections

Vanna PAPAEVANGELOU (G)

09:20-09:30

FREE COMMUNICATION 1

09:30-09:40

FREE COMMUNICATION 2

10:00-10:20

The value of neonatal imaging and beyond

Anne-Elodie MILLISCHER (F)

10:20-10:30

FREE COMMUNICATION 1

10:30-10:40

FREE COMMUNICATION 2

10:40-11:00

Discussion

11:00-11:30

COFFEE BREAK

11:30-12:30

INDUSTRIAL BREAKTHROUGHS

Chairs: Arnaud MARCHANT (F), Marianne LERUEZ (F)

Accreditations

CVS Ethical Medtech

The EMT20368-European Congenital Cytomegalovirus Initiative starting on 23-04-2020 in Paris, France is compliant with the MedTech Europe Code of Ethical Business.

For more information visit: www.ethicalmedtech.eu